Physician

Christopher John Evans, DO

According to 2025 Medicare claims, Christopher Evans, DO (NPI: 1063401263) practices general surgery in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is REGIONAL GASTROENTEROLOGY ASSOCIATES OF LANCASTER, LTD. (NPI: 1154422806; TIN: 232812220) and primary practice location at 17601-2644. Evans is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019), participating under the MSSP model.

Evans' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 254 traditional Medicare patients, billed 1,044 HCPCS/CPT codes, and received $55,544 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 196 prescription claims across 77 beneficiaries totaling $8,277 in drug costs, led by Sucralfate (Sucralfate). 2016 DME data shows 114 claims. Open Payments data shows 31 records totaling $753. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $77,583 to $55,544. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $4,103 to $8,277. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	224	617	$77,583
2016	188	509	$68,827
2017	284	768	$94,216
2018	202	433	$62,429
2019	167	417	$52,532
2020	137	344	$45,666
2021	133	322	$43,945
2022	128	328	$39,680
2023	155	324	$40,482
2024	254	1,044	$55,544

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	46	82	$4,103
2016	33	58	$3,753
2017	48	67	$2,845
2018	103	165	$11,448
2019	122	168	$10,159
2020	102	140	$8,832
2021	71	111	$7,017
2022	69	105	$5,699
2023	81	125	$6,540
2024	77	196	$8,277

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	243	$8,106
2016	N/R	114	$2,392
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	61	61	$198
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	49	49	$167
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	23	23	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	27	30	$67
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	45	45	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sucralfate	Sucralfate	26	357	$1,686
Pantoprazole Sodium	Pantoprazole Sodium	77	3,193	$692
Omeprazole	Omeprazole	27	1,015	$287
Dicyclomine Hcl	Dicyclomine Hcl	14	680	$274

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$753	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher John Evans, DO?

Tedicare shows public-source Medicare data for Christopher John Evans, DO (NPI 1063401263), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher John Evans, DO have ACO affiliation data?

Christopher John Evans, DO is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019).

What billing organization is linked to Christopher John Evans, DO?

Christopher John Evans, DO is linked to REGIONAL GASTROENTEROLOGY ASSOCIATES OF LANCASTER, LTD. (billing NPI 1154422806) in the available physician profile data.

Does Christopher John Evans, DO have Open Payments data?

Christopher John Evans, DO has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.